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increased chlamydia testing among Australian
general practitioners: a cross-sectional study of
chlamydia testing uptake in general practice
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Background: Female general practitioners (GPs) have higher chlamydia testing rates than male GPs, yet it is unclear
whether this is due to lack of knowledge among male GPs or because female GPs consult and test more female
patients.
Methods: GPs completed a survey about their demographic details and knowledge about genital chlamydia.
Chlamydia testing and consultation data for patients aged 16-29 years were extracted from the medical records
software for each GP and linked to their survey responses. Chi-square tests were used to determine differences in a
GP’s knowledge and demographics. Two multivariable models that adjusted for the gender of the patient were
used to investigate associations between a GP and their chlamydia testing rates ― Model 1 included GPs’
characteristics such as age and gender, Model 2 excluded these characteristics to specifically examine any
associations with knowledge.
Results: Female GPs were more likely than male GPs to know when to re-test a patient after a negative chlamydia
test (18.8% versus 9.7%, p = 0.01), the correct symptoms suggestive of PID (80.5% versus 67.8%, p = 0.01) and the
correct tests for diagnosing PID (57.1% versus 42.6%, p = 0.01). Female GPs tested 6.5% of patients, while male GPs
tested 2.2% (p < 0.01). Model 1 found factors associated with chlamydia testing were being a female GP (OR = 2.5,
95% CI: 1.9, 3.3) and working in a metropolitan clinic (OR = 3.2; 95% CI: 2.4, 4.3). Model 2 showed that chlamydia
testing increased as knowledge of testing guidelines improved (3-5 correct answers – AOR = 2.0, 95% CI: 1.0, 4.2;
6+ correct answers – AOR = 2.9, 95% CI: 1.4, 6.2).
Conclusions: Higher rates of chlamydia testing are strongly associated with GPs who are female, based in a
metropolitan clinic and among those with more knowledge of the recommended guidelines. Improving
chlamydia knowledge among male GPs may increase chlamydia testing.
Keywords: Chlamydia testing, General practice, Sexual health knowledge, General practitioner education* Correspondence: ayeung@unimelb.edu.au
1Centre for Epidemiology and Biostatistics, Melbourne School of Population
and Global Health, University of Melbourne, 207 Bouverie Street, Carlton,
Victoria, Australia
Full list of author information is available at the end of the article
© 2014 Yeung et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain
Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article,
unless otherwise stated.
Yeung et al. BMC Infectious Diseases 2014, 14:584 Page 2 of 12
http://www.biomedcentral.com/1471-2334/14/584Background
Chlamydia is the most common bacterial sexually transmis-
sible infection (STI) in Australia; notifications have risen
dramatically over the past decade, from 30 000 in 2003 to
more than 80 000 notifications in 2013 [1]. Over 80% of in-
fections in both men and women are asymptomatic [2] and
if left untreated, chlamydia can cause pelvic inflammatory
disease (PID) and progress to infertility in women [3,4].
In Australia, 80% of chlamydia cases are diagnosed in
the general practice setting, with the other 20% coming
from sexual health or family planning clinics, hospitals
and other specialist services [5]. The current Royal
Australian College of General Practitioners (RACGP)
Preventive Care Guidelines recommends annual testing
for all sexually active young people aged 15-29 years [6].
Although 75% of young people in this age group are
seen by general practitioners (GP) at least once a year
[7], testing rates remain below 10%. Modelling data has
shown that testing rates need to be increased to 30% or
more in order to reduce the prevalence of chlamydia [8].
Barriers to testing by GPs include lack of time, discom-
fort with sexual health issues [9] and lack of knowledge
about the benefits of chlamydia screening [10].
Higher self-reported chlamydia testing rates have been
found to be associated with being a female GP [11] or
having postgraduate qualifications in sexual health [12]
but the association between empirically measured chla-
mydia testing rates and a GP’s knowledge has not been
investigated. An audit of testing data in general practice
also found female GPs and GPs practicing in a major
city are more likely to test for chlamydia [13] but this
study did not consider the influence of GPs’ knowledge
about chlamydia diagnosis and management.
We had the opportunity to investigate associations be-
tween GP gender, their knowledge and their chlamydia
testing rates in an ongoing chlamydia testing trial in
general practice. As part of this trial, GPs were asked to
complete a survey about their knowledge of chlamydia
diagnosis and management. Survey responses were sub-
sequently correlated with their chlamydia testing data
for the 12 months prior to commencing the trial. This
paper presents these results and examines whether a
GP’s knowledge varies by GP gender and age, and
whether a GP’s demographic characteristics and sexual
health knowledge is associated with their chlamydia test-
ing rates.
Methods
Setting
The Australian Chlamydia Control Effectiveness Pilot
(ACCEPt) is a cluster randomised controlled trial that
aims to determine whether a chlamydia testing inter-
vention in general practice can lead to a reduction in
chlamydia prevalence in the population [14]. ACCEPt isusing a cluster design to reduce the likelihood of patients at-
tending both participatory and non-participatory clinics. A
total of 134 general practice clinics and Aboriginal medical
services in 54 rural and regional towns (clusters) in the
Australian states of Victoria, New South Wales, Queensland
and South Australia are enrolled in ACCEPt. A list of towns
was drawn up and towns were selected in no particular
order until the required sample size of 54 was reached. A
further nine general practice clinics from metropolitan areas
in Victoria were also recruited. Recruitment took place
between mid 2010 and December 2011. All GPs at each par-
ticipating clinic were consented into ACCEPt.
General practice in Australia
Primary care in Australia is largely provided by general
practice clinics and patients can choose to attend mul-
tiple different clinics, as opposed to the United Kingdom
where patients are required to register with one practice.
It is not guaranteed that a patient will always see the
same GP in each clinic, as this depends on GP availabil-
ity and the patient’s preference.
Questionnaire administration
On enrolment of the clinic, each GP was asked to
complete a survey on their knowledge of the diagnosis
and management of chlamydia. The GP was asked to re-
turn the paper survey to the researcher or mail it to the
Melbourne School of Population and Global Health at
the University of Melbourne. GPs were also consented
to allow their chlamydia testing and consultation data to
be extracted from the medical records software at the
clinic. Data from the survey were entered into a Micro-
soft Access database.
Questionnaire content and format
The survey was adapted from previous chlamydia survey
studies conducted by the University of Melbourne [10];
face and content validity was established by experts in
the field and then pilot tested with GPs. The survey in-
cluded demographic questions (age, sex, number of years
working in general practice, postgraduate qualifications),
knowledge based questions about age groups at greatest
risk of chlamydia, clinical presentation of chlamydia, an-
tibiotics for treating chlamydia, follow-up testing recom-
mendations and diagnosis and management of PID. A
variety of testing scenarios asked the GP to indicate how
likely they would be to offer a chlamydia test to the pa-
tient presenting in the scenario (for instance, an 18 year
old woman presenting with low abdominal pain) to de-
termine their knowledge about the recommended testing
guidelines. The majority of questions used a Likert scale
format to measure the GP’s response. Knowledge based
questions used a mix of multiple choice and free-text
space. Such questions aimed, for example, to determine
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tive chlamydia test.
Answers to the questions about epidemiology, clinical
presentation, antibiotic treatment and follow-up testing
were based on data from the National Notifiable Disease
Surveillance System, the RACGP guidelines, the Centers
for Disease Control and Prevention guidelines and the Na-
tional Management Guidelines for Sexually Transmissible
Infections, as well as input from two clinicians from the
ACCEPt investigator team on PID diagnosis. At the time
of the survey, the RACGP guidelines recommended test-
ing all sexually active young people between 15 and 25
[15] and the survey was based on these guidelines. How-
ever in 2012, revised guidelines were released recom-
mending testing young people up to 29 years of age
annually [6]. This analysis was based on the RACGP
guidelines available in 2010.
Chlamydia testing data
A data extraction tool (Grhanite™) was installed on a
computer in each clinic to extract medical record data
from the clinic’s patient records system. Further infor-
mation about Grhanite™ is provided by Boyle et al. [16]
and is available on the website [17]. This tool extracts
de-identified patient data about all consultations includ-
ing GP provider number (a unique GP identification
code), date of consultation, age and sex of patient,
whether the patient had a chlamydia test and the result
of the test. The chlamydia testing data obtained from
clinics using Grhanite™ against laboratory chlamydia
testing data has been previously validated [18]. Data
were extracted weekly from each clinic. For each GP
who completed the survey, the number of patients aged
16 to 29 years who had at least one chlamydia test was
divided by the number of patients who had consulted
that particular GP at least once during 2010. These data
were used to calculate an individual GP’s chlamydia test-
ing rate among patients aged 16 to 29 years for 2010,
and while we refer to it as a chlamydia testing ‘rate’
throughout this manuscript, it is actually a measure of
patients who had a chlamydia test proportionate to pa-
tients who had a consultation. To be included in the
analysis presented in this paper, a GP had to have
worked at the participating clinic for at least one month
in 2010 and completed the survey at the time of
enrolment.
Data analysis
Each GP’s chlamydia testing data were linked to their sur-
vey data by a unique study number and analysed in Stata™
(College Station, Texas). Chi-square tests were used to
examine differences between male and female GPs in their
demographic details and their knowledge about chlamydia
diagnosis and management. The questions using a Likertscale format were coded into binary answers (correct/incor-
rect or yes/no), with ‘don’t know’ or ‘not sure’ answers in-
cluded in the no or incorrect category. Free-text answers
were also coded into either correct or incorrect categories.
Each of the eight testing scenarios was coded as a binary
answer (offer test/not offer test) and then classified as either
correct or incorrect testing practices according to the 2010
RACGP chlamydia testing guidelines. The total number of
correct testing practices was then summed for each GP to
get a testing score out of eight. To evaluate knowledge
about the diagnosis and management of PID, GPs were
asked to indicate which signs and symptoms were suggest-
ive of PID from a list. They were classified as answering
correctly if they selected each of the following - tenderness
with motion of the cervix, adnexal tenderness, uterine ten-
derness, lower abdominal tenderness and inflamed cervix.
They were also asked to choose which tests could be used
to help diagnose PID in a general practice setting and were
classified as answering correctly if they selected each of the
following - pregnancy test, test for chlamydia and gonor-
rhoea, abdominal palpation and bimanual examination.
Logistic regression was used to assess associations be-
tween each GP’s chlamydia testing rates and their demo-
graphics and knowledge about the diagnosis and
management of chlamydia, and odds ratios and 95%
confidence intervals were calculated. An individual GP’s
chlamydia testing rate was included in the model as a bi-
nomial proportion where the numerator was the total
number of patients who had at least one chlamydia test
and the denominator was the total number of patients
who had at least one consultation. All analyses were
conducted using Stata 13 (College Station, Texas) and
used a generalised linear modelling command with a
logit link function and binomial family; both unadjusted
and multivariable analyses were undertaken. Initial ana-
lysis showed that female GPs had greater knowledge
about chlamydia and that being a female GP was the
variable most strongly predictive of chlamydia testing.
To enable us to examine the association of knowledge
with chlamydia testing, we present two multivariable
models. Model 1 included both the characteristics of the
GP – age, sex, location and interest in sexual health –
and knowledge variables. Variables that had a significant
association (p < 0.1) with testing in the unadjusted ana-
lysis were included in the multivariable analysis. Model
2 excluded the individual characteristics of the GP but
included all knowledge variables. Patient gender was in-
cluded in both Model 1 and Model 2 because previous
work has shown that female GPs are more likely to see
female patients [11] and testing rates are higher among
female patients than male patients [7].
The survey received ethical approval from the Royal
Australian College of General Practitioners Ethics Com-
mittee, the University of Melbourne Human Research
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Research Council.
Results
Response rates
A total of 457 GPs had chlamydia testing data available in
2010 and of these, 391 had completed a survey, resulting in
a response rate of 85.6%.Participants
The majority of GPs were male (66.0%), and most GPs were
trained in Australia (63.3%). Over half were aged between
45-59 years (52.9%) with less than 5% being under 30 years
of age (Table 1). The number of years working in general
practice averaged 17.2 years (interquartile range: 6 – 26).
Female GPs were more likely to be younger, to work fewer
sessions per week and to have an interest in sexual health
than male GPs (all p < 0.01).
Knowledge
While over 90% of GPs knew infection in women was
usually asymptomatic, only 74% knew infection in men
was also usually asymptomatic (Table 2). Over 80% knewTable 1 Characteristics of participating GPs
Characteristic Overall N
Gender of GP
Location of GP clinic Rural 346 (88.5)
Metropolitan 45 (11.5)
GP Age Group (years) <30 13 (3.3)
30-44 124 (31.7)
45-59 207 (52.9)
>60 47 (12.0)
Years working in general practice <5 74 (19.2)
5-10 40 (10.4)
10-20 89 (23.1)
20-30 117 (30.3)
30+ 66 (17.1)
Country of medical training Australia 247 (63.3)
Overseas 143 (36.7)
Number of clinic sessions per week <5 35 (9.2)
5-9 267 (70.3)
10+ 78 (20.5)
Postgraduate qualifications1 No 117 (29.9)
Yes 274 (70.1)
Interest in sexual health No 284 (73.8)
Yes 101 (26.2)
1Qualifications include Diploma of Obstetrics & Gynaecology, Diploma of Venereolo
Royal Australian and New Zealand College of Obstetricians and Gynaecologists, Fell
Australian College of Rural and Remote Medicine.the correct treatment for non-complicated chlamydia in-
fection, but only about 40% knew that azithromycin
should be used as the first line treatment for chlamydia
during pregnancy. Knowledge about correct re-testing
intervals after either a negative test (12 months) or a
positive test result (3 months) was poor, 12.8% and
21.2% respectively. Female GPs were more likely than
male GPs to indicate that they would conduct a chla-
mydia test for a 23 year old woman presenting for a pap
smear (66.9% versus 46.9%, p < 0.01) and according to
the RACGP Guidelines in 2010, more likely to incor-
rectly test a 26 year old man presenting for a truck li-
cense (26.3% versus 15.6%, p = 0.01) and a 33 year old
woman presenting for an oral contraceptive prescription
(21.1% versus 12.1%, p = 0.02).
Female GPs were more likely than male GPs to
know when to re-test a patient after a negative chla-
mydia test (18.8% versus 9.7%, p = 0.01), were more
likely to correctly know the symptoms suggestive of
PID (80.5% versus 67.8%, p = 0.01) and which tests
should be used for diagnosing PID (57.1% versus
42.6%, p = 0.01). No other significant differences in
knowledge between male and female GPs were
observed.(%) Male GP N (%) Female GP N (%) p-value
258 (66.0) 133 (34.0) <0.01
234 (90.7) 112 (84.2) 0.06
24 (9.3) 21 (15.8)
6 (2.3) 7 (5.3) <0.01
70 (27.1) 54 (40.6)
143 (55.4) 64 (48.1)
39 (15.1) 8 (6.0)
41 (16.1) 33 (25.0) <0.01
18 (7.1) 22 (16.7)
57 (22.4) 32 (24.2)
83 (32.7) 34 (25.8)
55 (21.7) 11 (8.3)
161 (62.7) 86 (64.7) 0.70
96 (37.4) 47 (35.3)
11 (4.4) 24 (18.5) <0.01
176 (70.4) 91 (70.0)
63 (25.2) 15 (11.5)
75 (29.1) 42 (31.6) 0.61
183 (70.9) 91 (68.4)
207 (80.9) 77 (59.7) <0.01
49 (19.1) 52 (40.3)
gy/Sexual Health, Certificate of the Family Planning Association, Fellow of the
ow of the Royal Australian College of General Practitioners, Fellow of the
Table 2 Knowledge about chlamydia diagnosis and management by GP gender
Variable Overall N (%) Male GP N (%) Female GP N (%) p-value
Female age groups at highest risk of infection1 Incorrect 24 (6.3) 16 (6.4) 8 (6.1) 0.91
Correct 244 (93.8) 236 (93.7) 124 (93.9)
Male age groups at highest risk of infection2 Incorrect 39 (10.4) 24 (9.8) 15 (11.5) 0.63
Correct 336 (89.6) 220 (90.2) 116 (88.6)
Chlamydia is usually asymptomatic in Women Disagree 32 (8.3) 20 (7.9) 12 (9.0) 0.70
Agree 355 (91.7) 234 (92.1) 121 (91.0)
Chlamydia is usually asymptomatic in Men Disagree 100 (26.0) 67 (26.6) 33 (24.8) 0.71
Agree 285 (74.0) 185 (73.4) 100 (75.2)
Knowledge of population groups to be targeted for screening3 (see below for results for each scenario) 0-2 24 (6.2) 19 (7.5) 5 (3.8) 0.09
3-5 264 (68.6) 177 (70.2) 87 (65.4)
6+ 97 (25.2) 56 (22.2) 41 (30.8)
Treatment in men and non-pregnant women4 Incorrect 70 (17.9) 49 (19.0) 21 (15.8) 0.43
Correct 321 (82.1) 209 (81.0) 112 (84.2)
Treatment in pregnant women4 Incorrect 231 (59.1) 146 (56.6) 85 (63.9) 0.16
Correct 160 (40.9) 112 (43.4) 48 (36.1)
Retest 12 months after a negative test5 Incorrect 341 (87.2) 233 (90.3) 108 (81.2) 0.01
Correct 50 (12.8) 25 (9.7) 25 (18.8)
Retest 3 months after a positive test5 Incorrect 308 (78.8) 207 (80.2) 101 (75.9) 0.33
Correct 83 (21.2) 51 (19.8) 32 (24.1)
Knowledge of symptoms suggestive of PID6 Incorrect 109 (27.9) 83 (32.2) 26 (19.6) 0.01
Correct 282 (72.1) 175 (67.8) 107 (80.5)
Knowledge of PID tests that should be done7 Incorrect 205 (52.4) 148 (57.4) 57 (42.9) 0.01
Correct 186 (47.6) 110 (42.6) 76 (57.1)
Testing Scenarios
Case 1: 23 year old female, pap smear Not offer test 180 (46.3) 136 (53.1) 44 (33.1) <0.01
Offer test 209 (53.7) 120 (46.9) 89 (66.9)
Case 2: 18 year old female, abdominal pain Not offer test 19 (4.9) 16 (6.2) 3 (2.3) 0.08
Offer test 371 (95.1) 241 (93.8) 130 (97.7)
Case 3: 26 year old male, truck license medical Not offer test 315 (80.8) 217 (84.4) 98 (73.7) 0.01
Offer test 75 (19.2) 40 (15.6) 35 (26.3)
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Table 2 Knowledge about chlamydia diagnosis and management by GP gender (Continued)
Case 4: 24 year old female, 16/40 pregnant Not offer test 228 (58.8) 151 (59.2) 77 (57.9) 0.80
Offer test 160 (41.2) 104 (40.8) 56 (42.1)
Case 5: 22 year old male, Aboriginal, sore throat Not offer test 271 (69.5) 178 (69.3) 93 (69.9) 0.89
Offer test 119 (30.5) 79 (30.7) 40 (30.1)
Case 6: 33 year old female, pill script Not offer test 330 (84.8) 225 (87.9) 105 (79.0) 0.02
Offer test 59 (15.2) 31 (12.1) 28 (21.1)
Case 7: 17 year old male, genital warts Not offer test 12 (3.1) 11 (4.3) 1 (0.8) 0.06
Offer test 378 (96.9) 246 (95.7) 132 (99.3)
Case 8: 34 year old male, 2 partners in last 6 months, HIV test Not offer test 10 (2.6) 6 (2.3) 4 (3.0) 0.70
Offer test 379 (97.4) 250 (97.7) 129 (97.0)
1Answers were classified as correct if they ticked at least one correct answer - 15-19 and 20-24 year olds; 2Answers were classified as correct if they ticked at least one correct answer - 20-24 and 25-29 year olds;
3Knowledge of population groups to be targeted for screening is one point for correctly offering a test under the 2010 RACGP guidelines – tests should be offered to cases 1, 2, 4, 5, 7 & 8 but not offered to cases 3 &
6; 4Azithromycin is the correct treatment for men, women and pregnant women; 5RACGP guidelines recommend re-testing every 12 months after a negative test and every 3 months after a positive test; 6Correct signs
and symptoms suggestive of PID are tenderness with motion of the cervix, adnexal tenderness, uterine tenderness, lower abdominal tenderness and inflamed cervix; 7Correct diagnostic tests are pregnancy test,
chlamydia and gonorrhoea test, abdominal palpation and bimanual examination.
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The overall testing rate in 2010 was 3.7% (95% CI: 2.9%,
4.4%) for 16-29 year old patients. Female GPs had a higher
testing rate in 2010 of 6.5% (95% CI: 5.1%, 7.9%) than male
GPs (2.2%; 95% CI: 1.4%, 3.0%; p < 0.01). In addition, youn-
ger GPs also had a higher testing rate irrespective of the
gender of the GP; GPs aged less than 30 years tested 6.5%
(95% CI: 4.2%, 8.9%) while GPs aged 60 and over tested
2.3% (95% CI: 0.6%, 4.0%) of 16-29 year olds. Those prac-
ticing in rural areas had a lower testing rate of 5.5% (95%
CI: 4.7%, 6.2%) than those practicing in metropolitan areas
(9.0%; 95% CI: 6.5%, 11.6%).
Factors associated with chlamydia testing
Multivariable model 1 showed that being a female GP
(Adjusted OR [AOR] =2.5; 95% CI: 1.9, 3.3), having an
interest in sexual health (AOR = 1.3, 95% CI: 1.0, 1.7),
and working in a metropolitan area (AOR = 3.2; 95% CI:
2.4, 4.3) were associated with an increased odds of test-
ing. An increase in the age of the GP was associated
with lower rates of testing (45-59 years old: AOR = 0.5,
95% CI: 0.3, 0.7; 60+ years old: AOR = 0.4, 95% CI: 0.3,
0.7; relative to GPs aged <30). No knowledge variables
were independently associated with chlamydia testing
(Table 3).
Multivariable model 2 showed that GPs with increas-
ing knowledge of the correct testing guidelines were
more likely to test (3-5 correct answers – AOR =2.0,
95% CI: 1.0, 4.2; 6+ correct answers – AOR = 2.9; 95%
CI: 1.4, 6.2; relative to those with 0-2 correct answers).
GPs who knew the correct treatment for chlamydia in
pregnant women had lower odds of testing (AOR = 0.6,
95% CI: 0.4, 0.9). No other factors were independently
associated with chlamydia testing (Table 3).
Discussion
Our analysis is the first to link GPs’ chlamydia testing
rates with their knowledge about chlamydia and to
examine the association of knowledge with GP gender.
We found the strongest independent predictors of chla-
mydia testing were being a female GP and being based
in a metropolitan clinic. When the individual GP charac-
teristics were excluded from the multivariable model, we
found that GPs with knowledge of who should be tested
according to the RACGP guidelines had increasing chla-
mydia testing rates.
The strengths of this study include its high response rate
of over 85%, representation of GPs from four Australian
states (Victoria, New South Wales, Queensland and South
Australia), and that gender of patient was controlled for in
the analysis. Controlling for gender of patient was import-
ant because testing rates are higher in female than male pa-
tients [7] and female GPs are more likely than male GPs to
consult with female patients [19]. However, a limitation ofour analysis was that over 80% of GPs were from rural
clinics, leading to an underrepresentation of GPs working
in metropolitan clinics. Given that GPs working in metro-
politan clinics were more likely to have higher chlamydia
testing rates, the results of our study may not be represen-
tative of GPs overall.
In this study, female GPs had significantly greater
knowledge than male GPs about who should be tested
for chlamydia, when to conduct repeat testing after a
negative test and the diagnosis and management of PID.
Additionally, GPs with increased knowledge about who
should be tested for chlamydia had higher testing rates.
This suggests that if we can increase GP knowledge
about the diagnosis and management of chlamydia, chla-
mydia testing rates should increase. While continuing
medical education is frequently cited as a facilitator to
increased chlamydia testing [10], national leadership is
needed to improve the quality and effectiveness of sexual
health education for GPs, particularly male GPs. Given
that females make up only 41% of the general practice
workforce in Australia [20] and there are fewer female
GPs available in rural areas than metropolitan areas, the
results of our study show that addressing these gender
differences in sexual health knowledge is imperative to
improve chlamydia testing access for all young adults
across Australia.
It is likely that the strong association between chla-
mydia testing and female GPs is ingrained in the culture
of general practice. Firstly, females are more likely to at-
tend general practice than males [21] and they are more
likely to attend for a sexual health related consultation
such as contraceptive advice and pap smears, contexts
where an offer of a chlamydia test is easier [22]. Sec-
ondly, as the consequences of untreated chlamydia have
a greater impact on women, it is possible that female
GPs are more conscious about the importance of chla-
mydia testing [23]. Burd and colleagues investigated the
impact of physician gender on sexual history taking in
the USA and found that male physicians were more
likely than female physicians to report discomfort in
taking a sexual history from a female patient (35% ver-
sus 12%) and to perceive that female patients were un-
comfortable with having their sexual history taken (53%
versus 24%) [24] which may impact their chlamydia test-
ing rates. We also found that testing rates decreased
with increasing age of the GP, although this may be due
to patients self-selecting younger doctors for STI test-
ing. Data show that younger patients prefer a younger
female GP because they consider them to be less conserva-
tive and easier to relate to than older GPs [25]. Conversely,
older GPs with an older patient base may be less mindful of
chlamydia testing and use guidelines less frequently [26].
It is possible that receiving a positive chlamydia test
result for a patient may motivate a GP to test more as
Table 3 GP characteristics and knowledge variables associated with chlamydia testing1
GP variable Odds
ratio
95% CI p-value Adjusted OR2
(including GP characteristics)
95% CI p-value Adjusted OR2
(excluding GP characteristics)
95% CI p-value
Gender of GP Male 1.0 1.0
Female 3.1 2.1, 4.7 <0.01 2.5 1.9, 3.3 <0.01
Location Rural 1.0 1.0
Metro 2.3 1.4, 3.6 <0.01 3.2 2.4, 4.3 <0.01
Age Group <30 1.0 1.0
30-44 0.8 0.5, 1.2 0.27 0.7 0.5, 1.1 0.13
45-59 0.6 0.3, 0.9 0.02 0.5 0.3, 0.7 <0.01
60+ 0.4 0.1, 1.3 0.13 0.4 0.3, 0.7 <0.01
Years in general practice <5 1.0
5-10 1.0 0.6, 1.7 0.91
10-20 0.9 0.6, 1.5 0.81
20-30 0.8 0.4, 1.5 0.48
30+ 0.4 0.1, 1.3 0.11
Country of training Australian 1.0
trained
Overseas
trained
0.8 0.5, 1.2 0.31
Interest in sexual health No 1.0 1.0
Yes 1.7 1.0, 2.7 0.04 1.3 1.0, 1.7 0.03
Postgraduate qualifications No 1.0
Yes 1.2 0.7, 1.9 0.56
Female age groups at highest risk of
infection3
Incorrect 1.0 1.0 1.0
Correct 1.8 1.0, 3.1 0.05 1.6 0.7, 3.5 0.26 1.5 0.7, 3.5 0.31
Male age groups at highest risk of
infection4
Incorrect 1.0 1.0 1.0
Correct 1.6 0.9, 2.9 0.08 1.4 0.8, 2.7 0.23 1.6 0.9, 2.9 0.10
Chlamydia is usually asymptomatic in
Women
Disagree 1.0 1.0
Agree 1.4 0.9, 2.3 0.18 1.2 0.7, 2.1 0.44
Chlamydia is usually asymptomatic in
Men
Disagree 1.0 1.0 1.0
Agree 1.6 1.1, 2.2 0.01 1.4 1.0, 1.9 0.03 1.4 0.9, 1.9 0.10
Knowledge of population groups to
be targeted for screening5
0-2 1.0 1.0 1.0
3-5 2.0 1.0, 4.0 0.05 1.7 0.8, 3.8 0.16 2.0 1.0, 4.2 0.07
6+ 3.4 1.7, 6.8 <0.01 2.0 0.9, 4.4 0.08 2.9 1.4, 6.2 <0.01
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Table 3 GP characteristics and knowledge variables associated with chlamydia testing1 (Continued)
Treatment in men and non-pregnant
women6
Incorrect 1.0 1.0
Correct 1.0 0.4, 2.3 0.97 1.0 0.5, 2.2 0.92
Treatment in pregnant women6 Incorrect 1.0 1.0
Correct 0.7 0.5, 1.0 0.11 0.6 0.4, 0.9 0.01
Retest at 12 months after a negative
test7
Incorrect 1.0 1.0 1.0
Correct 1.8 0.9, 3.5 0.08 1.2 0.9, 1.6 0.32 1.5 0.9, 2.6 0.16
Retest at 3 months after a positive
test7
Incorrect 1.0 1.0
Correct 1.0 0.7, 1.5 0.97 0.9 0.6, 1.4 0.73
Knowledge of symptoms suggestive
of PID8
Incorrect 1.0 1.0
Correct 1.3 0.7, 2.2 0.38 1.3 0.8, 2.0 0.34
Knowledge of PID tests that should
be done9
Incorrect 1.0 1.0 1.0
Correct 1.5 0.9, 2.3 0.09 0.9 0.7, 1.2 0.41 1.1 0.8, 1.7 0.51
Gender of patient2 Male 1.0 1.0 1.0
Female 2.3 1.7, 3.1 <0.01 1.9 1.5, 2.4 <0.01 2.2 1.7, 2.9 <0.01
1Accounted for repeated measures from individuals GPs; 2The multivariable models have adjusted for patient gender; 3Answers were classified as correct if they ticked at least one correct answer - 15-19 and 20-24 year
olds; 4Answers were classified as correct if they ticked at least one correct answer - 20-24 and 25-29 year olds; 5Knowledge of population groups to be targeted for screening is one point for correctly offering a test
under the 2010 RACGP guidelines – tests should be offered to cases 1, 2, 4, 5, 7 & 8 but not offered to cases 3 & 6; 6Azithromycin is the correct treatment for men, women and pregnant women; 7RACGP guidelines
recommend re-testing every 12 months after a negative test and every 3 months after a positive test; 8Correct signs and symptoms suggestive of PID are tenderness with motion of the cervix, adnexal tenderness,
uterine tenderness, lower abdominal tenderness and inflamed cervix; 9Correct diagnostic tests are pregnancy test, chlamydia and gonorrhoea test, abdominal palpation and bimanual examination.
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http://www.biomedcentral.com/1471-2334/14/584previous research has shown that GPs who reported
testing symptomatic patients weekly were more likely to
also test asymptomatic patients compared to GPs who
tested symptomatic patients less often [11]. We were un-
able to investigate the effect of positive results in this
analysis because of the cross-sectional design and that
data were unavailable for 2009, the year prior to our
analysis. However, future longitudinal data analyses aris-
ing from ACCEPt will investigate the impact of chla-
mydia test results on future GP testing performance.
We found that during 2010, chlamydia testing rates
were 3.7% among those aged 16 to 29 years, much lower
than the 8.9% previously reported for Australian general
practice [7]. This is likely due to the fact that we report
here testing rates per GP rather than per clinic, as we
are examining the associations between individual GP
characteristics, knowledge and testing rates and patients
may attend multiple different GPs at different times
within each clinic. Patients who attended in 2010 would
have only been eligible for one chlamydia test across the
clinic, instead of a chlamydia test with each GP they
consulted. When we examined chlamydia testing rates
per clinic in our dataset, we found a chlamydia testing
rate of about 10% per year, comparable to the earlier re-
port [7].
In this study, only 21.2% of GPs identified the ideal
follow-up interval following a positive chlamydia test as
three months, with 56.3% reporting that they would re-test
before 3 months. Similarly, Heal and colleagues surveyed a
small group of GPs in northern Queensland and found that
54% of GPs re-tested at six weeks [27], although test of cure
after treatment is not recommended over concerns about
non-viable DNA being detected up to 4 weeks after treat-
ment [28], and a test of re-infection at three months is in-
stead advised. Inconsistent recommendations on follow-up
testing after a positive result from the RACGP guidelines
(3-12 months) [6] and the National Management Guide-
lines for STIs (three months) [29] may be a source of con-
fusion. This highlights the need for consensus in guideline
documents across Australia and national leadership from
the Australasian Sexual Health Alliance [30] in promoting
the new management guidelines released in August 2014 to
all Australian GPs.
It was a concern that only about 40% of GPs correctly an-
swered that one gram azithromycin is the recommended
first line treatment for chlamydia infection during preg-
nancy, as untreated chlamydia can have consequences on
pregnancy and neonates [31]. In the multivariable model
that excluded GP characteristics, we found that GPs with
correct knowledge about treatment during pregnancy had
lower chlamydia testing rates. This is difficult to interpret
and probably occurred as an artefact because there was
some evidence that the male GPs in our sample did have
better knowledge about correct treatment during pregnancythan females (43% versus 36%, p = 0.16), and male GPs also
had lower testing rates on average compared with female
GPs.
The higher chlamydia testing rates observed among
metropolitan GPs requires further discussion and raises is-
sues of equity. Firstly, people living in rural areas do have
reduced access to primary care compared with those living
in metropolitan areas. There are fewer GPs per capita in
rural areas, patients have to wait longer for a consultation
[32] and there are fewer females GPs available [33]. This
contributes to reduced possibilities for chlamydia testing
among those living in rural areas which may lead to higher
chlamydia prevalence in rural areas as recently confirmed
in a survey of men and women aged 16-29 years attending
general practice that found chlamydia prevalence was
slightly higher in rural areas compared to metropolitan
areas (4.8% versus 3.1%, p = 0.08) [34]. Secondly, there are
issues for young people seeking sexual health care treat-
ment in rural areas with young people reporting fear, em-
barrassment or shame where ‘everyone knows each other’
[35]. However, we recently found in a survey of 3724 men
and women aged 16 to 29 years living in rural Australia,
70% will agree to have a chlamydia test when offered by
their GP [34]. This suggests that young people may not ac-
tively seek a test, but will accept one if asked by their GP.
Conclusion
We have linked GP chlamydia testing rates with GP’s
knowledge of chlamydia and found that testing rates are
higher among female GPs, those working in metropolitan
areas, those with an interest in sexual health and among
those with greater knowledge of the RACGP chlamydia
testing guidelines while lower testing rates were associated
with older GPs. These findings highlight the need for im-
proved quality and effectiveness of sexual health education
for GPs, particularly male GPs and given the disparities in
health care access between metropolitan and rural areas,
this is urgently needed if we are to address potential equity
issues around sexual health service access.
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